Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oblimersen + FOLFOX4 in Advanced Colorectal Cancer
NCT00055822Phase 2Completed
- Sponsor
- UT Health San Antonio
- Start
- Oct 2002
- Primary completion
- Oct 2004
- Modality
- Small Interfering RNA (siRNA), Modified DNA Oligonucleotides, Single-strand DNA
- Countries
- 1
01
Overview
A Phase 2 trial of oblimersen in colorectal cancer (CRC), sponsored by UT Health San Antonio. Started Oct 2002; status: completed.
02
Drugs
oblimersen
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT00055822.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00055822.